Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to -$6.7 million.

  • Prestige Consumer Healthcare's Cash from Financing Activities rose 8750.21% to -$6.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$129.5 million, marking a year-over-year increase of 4584.34%. This contributed to the annual value of -$182.1 million for FY2025, which is 2445.49% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Cash from Financing Activities of -$6.7 million as of Q4 2025, which was up 8750.21% from -$74.9 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's Cash from Financing Activities' 5-year high stood at $63.6 million during Q2 2021, with a 5-year trough of -$83.7 million in Q1 2021.
  • For the 5-year period, Prestige Consumer Healthcare's Cash from Financing Activities averaged around -$40.9 million, with its median value being -$53.7 million (2023).
  • The largest annual percentage gain for Prestige Consumer Healthcare's Cash from Financing Activities in the last 5 years was 16710.67% (2021), contrasted with its biggest fall of 64787.7% (2021).
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Cash from Financing Activities stood at -$67.6 million in 2021, then surged by 85.18% to -$10.0 million in 2022, then tumbled by 547.07% to -$64.8 million in 2023, then increased by 16.93% to -$53.9 million in 2024, then skyrocketed by 87.5% to -$6.7 million in 2025.
  • Its last three reported values are -$6.7 million in Q4 2025, -$74.9 million for Q3 2025, and -$36.3 million during Q2 2025.